Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Quick Facts TypeDual GIP/GLP-1 Receptor Agonist CategoryWeight Loss / Metabolic AdministrationSubcutaneous injection, once weekly FrequencyOnce weekly Typical Dose2.5 15 mg/week (titrated) Cycle LengthOngoing (chronic therapy) Available Sizes5 mg, 10 mg, 30 mg, 60 mg vials Stability56 days after reconstitution Overview What is Tirzepatide
Data availability Information for this narrative review paper is taken from freely available sources
The solution typically has a slightly yellow or clear appearance, which is normal for tirzepatide with B12
With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight management and type 2 diabetes
US$ 20.16
US$ 29.76
US$ 21.62
US$ 27.58
US$ 24.13
US$ 25.84
